Sun Pharma withdraws 11 eye medicines
Sun Pharma has initiated a voluntary recall of 11 ophthalmic products, instructing distributors and retailers to halt supply and remove existing stock from the market. While the company cited patient safety and precautionary measures, it has not disclosed specific reasons for the withdrawal or confirmed if manufacturing defects are involved.
Why it matters
The withdrawal of widely prescribed eye medications for conditions like glaucoma and infections could disrupt patient treatment plans and raises questions regarding pharmaceutical quality control standards.
NEW DELHI: Eleven ophthalmic products marketed by Sun Pharma have been withdrawn after the company's distribution arm directed retailers to stop further supply and withdraw existing stocks from the trade channel, according to a communication accessed by TOI. The July 17 communication instructed distributors to discontinue further distribution of the products.The products covered are Depopred 2ml, Brinolar (BKC Free), Brinzotim Eye Drops 5ml (BKC Free), Lotepred 5ml, Lotepred 1% Eye Drops 5ml, Lotepred LS 0.2% Eye Drops 5ml, Lotepred T, Nepalact OD Eye Drops 3ml, Nepalact-Z, Toba-F and…
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in